Alcocer Luis, Chavez Adolfo, Gomez-Alvarez Enrique, Espinosa Cutberto, Pombo Jose, Beaney Thomas, Ster Anca Chis, Poulter Neil R
Instituto Mexicano de Salud Cardiovascular, Tuxpan 16, Cuauhtemoc, Mexico City 06760, Mexico.
Centro Médico Nacional Siglo XXI, IMSS, Avenida Cuauhtemoc 330, Mexico City 06720, Mexico.
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H89-H91. doi: 10.1093/eurheartj/suaa036. Epub 2020 Aug 28.
In 2015, arterial hypertension was responsible for 18.1% of the total deaths in Mexico and its mortality rate has increased to 29.9% in the last 6 years. It is currently the main risk factor for preventable premature deaths of adults in the country. Good quality epidemiological information is the first step to improve health services. May Measurement Month 2018 (MMM18) in Mexico is an opportunistic survey, which follows the previously published methodology. MMM18 included screening 10 139 participants, 2187 (21.6%) of whom were classified as having hypertension. Of these, 42.0% were aware of the condition before measurement, and 38.0% were on medication, of which 66.5% were controlled. Hence, of all hypertensive patients, 25.3% were controlled (<140/90 mmHg). MMM18 in Mexico provides complementary data to the existing information on arterial hypertension in the country and helps to increase the visibility of hypertension: a priority health problem.
2015年,动脉高血压导致墨西哥18.1%的总死亡人数,且在过去6年中其死亡率已升至29.9%。目前,它是该国成年人可预防过早死亡的主要风险因素。高质量的流行病学信息是改善卫生服务的第一步。墨西哥2018年5月测量月(MMM18)是一项机会性调查,遵循先前公布的方法。MMM18包括对10139名参与者进行筛查,其中2187人(21.6%)被归类为患有高血压。在这些人中,42.0%在测量前知晓病情,38.0%正在服药,其中66.5%得到控制。因此,在所有高血压患者中,25.3%得到了控制(血压<140/90 mmHg)。墨西哥的MMM18为该国现有的动脉高血压信息提供了补充数据,并有助于提高高血压这一优先健康问题的关注度。